Login to Your Account

Northfield To Support PolyHeme Pivotal Trial With $15M Financing

By Aaron Lorenzo

Tuesday, January 27, 2004
Blood substitute developer Northfield Laboratories Inc. topped off the tank with $15 million in financing to fund a pivotal trial of its lead product, PolyHeme. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription